Endoscope Reprocessing Market – Global Outlook & Forecast 2022-2027

Endoscope Reprocessing Market – Global Outlook & Forecast 2022-2027

The global endoscope reprocessing market is expected to grow at a CAGR of 8.37% during 2022-2027.

Endoscope reprocessing is a multi-step process that involves effective cleaning, disinfection, and sterilization of endoscopy devices and their accessories. The high risk of infections associated with improper sterilization of endoscopes is majorly driving the demand for reprocessing equipment. The endoscope reprocessing market will be flourishing due to a focus on high cleaning standards and mounting pressures for sterilized and disinfected medical devices in hospitals and clinics.

The high usage of endoscopic devices mainly drives the global endoscope reprocessing market for diagnosis and treatment. This is due to the growing burden of various digestive and respiratory tract disorders that require endoscopy. Frequent use of these endoscopic instruments leads to an increased risk of infections; hence, these are being disinfected and cleaned using reprocessing systems. The demand for these systems is likely to grow in healthcare centers, but however, the high cost of endoscopy, improper or under reprocessing leading to infections, and the growing prominence of single-use bio processors can hinder the growth of the market.

Gastrointestinal (GI) endoscopy is an essential tool for identifying and treating gastrointestinal tract disorders. Gastrointestinal endoscopes can become highly contaminated with their frequent use in patients, as millions of endoscopy procedures are being performed in the US alone. Cleaning, disinfection, and sterilization process are vital for the prevention of infections caused due to the contamination of these endoscopes. Hence the demand for reprocessing the endoscopes has become highly important.

MARKET TRENDS & DRIVERS

  • The rise in Target Population Requiring Endoscopic Interventions
  • Growing Risk of Developing Endoscope-Related Infections
  • Regulatory Guidelines Promoting Usage of Endoscope Reprocessing
  • Increasing Hospital Investments in Endoscopes & Reprocessing Systems
RISK OF GROWING TARGET POPULATION AND DEVELOPMENT OF ENDOSCOPIC INFECTIONS

The number of patients suffering from gastrointestinal diseases is rising across the world. These diseases are among the most costly and debilitating health conditions, accounting for about 3 million hospital admissions in the United States alone. The prevalence of these diseases is increasing the need for performing endoscopic procedures in various healthcare centers. An estimated 17 million lower GI endoscopies and about the same number of upper endoscopies are performed annually in the US. This initiates the risk of infections associated with the formation of biofilms due to their frequent usage. The infection rate approaches 1 in 10 million procedures. With the growing risk of these infections, the demand for endoscope reprocessing systems is growing.

THE GROWING TREND OF INCORPORATING TRACKING SOLUTIONS

Proper endoscope reprocessing is vital for patient safety. Ensuring that every step in the process is completed needs complex tracking and documentation. Eliminating manual documentation logs and ensuring the endoscope is disinfected and cleaned before using it in the procedure. Significant benefits of these tracking solutions include improved handling of endoscope complexity, integration with multiple systems, quality assurance of workflow, and optimization of return on investment.

TECHNOLOGICAL ADVANCEMENTS DRIVING MARKET GROWTH

Several manufacturers are emphasizing automation of the disinfection workflows to a large extent. This has also defined their production advancements and innovation strategies in recent years. For instance, in 2018, around $0.4 billion was invested by Olympus to enhance their systems for performing tests to check cleaning and disinfection effectiveness. The cleaning has always been challenging owing to the inability to inspect the cleanliness inside the lumens of an endoscope until now. The latest technological advancements have allowed the development of flexible inspection camera systems that can check an instrument's internal channels for debris and damage, which could help reduce infection rates.

HIGH COST OF ENDOSCOPY PROCEDURES AND REPROCESSING EQUIPMENT

The high cost associated with endoscopy lowers the number of endoscopic procedures performed on patients. Medical procedures such as endoscopies can be costly without insurance. The cost of a colonoscopy typically ranges between $1,250 to over $4,800 in the US, with an endoscopy's national average price of $2,750. Also, the cost of the equipment ranges from $114.07 to $280.71. The average reported repair cost—whether attributed to a leak test failure, damage during a visual inspection, or a failed cleaning verification test was estimated to be $5,833. Such high prices can limit the adoption of re-processing equipment.

IMPACT OF COVID-19 ON THE GLOBAL ENDOSCOPE REPROCESSING MARKET

Gastrointestinal complaints were frequent among COVID-19 patients, with possible occurrences of diarrhea, nausea, and vomiting. A March 2020 multicenter survey revealed near-universal exposure to COVID-19 positive patients in endoscopy units: 97.6% experienced a reduction in endoscopic activities, and 50% performed endoscopic procedures on COVID-19 positive patients. Hence, there was a moderate need for performing endoscopy procedures during COVID-19. Due to this, the demand for endoscope re-processing systems was high as there was a high risk of disease transmission among patients and healthcare providers.

MARKET SEGMENTATION

PRODUCT

In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market. The demand for disinfectants is high as there is a growing need for disinfecting endoscopes. By equipment, the market is segmented as automated endoscope reprocessors and disinfection & sterilization equipment. Automated reprocessors accounted for the highest share in the market compared to disinfection & sterilization systems as the demand for automatic reprocessing systems is proliferating owing to their advanced features and better reprocessing.

END-USER

The end-user market includes hospitals, specialty clinics & medical office suites, standalone service facilities, and others. In 2021, hospitals accounted for the highest share of the global endoscopy device cleaning market. The use of endoscopic devices is high ins hospitals as these perform an increased number of endoscopic procedures compared to other healthcare settings. However, standalone reprocessing service facilities will likely witness the fastest growth during the forecast period.

Market Segments

Product:
  • Reprocessing Equipment
  • Disinfectants
  • Detergents
  • Drying, Storage & Transport Systems
  • Others
End-User
  • Hospitals
  • Specialty Clinics & Medical Office Suites
  • Standalone Reprocessing Service Facilities
  • Others:
GEOGRAPHY

In 2021, North America accounted for the highest share of the global endoscope reprocessing market. Significant factors contributing to the growth of endoscope reprocessing market share in the North America region include a rise in the number of endoscopic procedures performed, high demand for sterilizing and disinfecting endoscopic devices, increasing prevalence of digestive disorders, guidelines promoting safe procedures, and technological advancements in the systems and accessories. However, the APAC region will likely witness the fastest growth during the forecast period.

North America
  • US
  • Canada
Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
APAC
  • Japan
  • China
  • India
  • South Korea
  • Australia
Latin America
  • Brazil
  • Mexico
  • Argentina
Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • South Africa
COMPETITIVE SCENARIO

The global market is highly competitive, with international, regional, and local players offering a broad range of products and accessories. Leading vendors such as STERIS, Ecolab, Getinge AB, Olympus, and ASP (acquired by Fortive) are coming up with several strategies such as partnerships, collaborations, joint ventures, mergers, and acquisitions for their growth and establishment in the industry.

For instance, STERIS recently agreed to acquire Cantel Medical, a global provider of infection prevention products and services primarily to endoscopy and dental customers.

Ecolab has developed vanBaerle, offering a full range of cleaning, disinfectant, and hygiene solutions, which can contribute to Ecolab's growth in cleaning and disinfectant products.

Product launches from these vendors are advancing the global endoscope reprocessing market. For instance, in 2020, Olympus launched its OER-Elite next-generation automated endoscope reprocessing system.

Key Vendors:
  • STERIS
  • Ecolab
  • Getinge AB
  • Olympus
  • Fortive
Other Prominent Vendors
  • 3M
  • ATMS
  • Metall Zug
  • BES Healthcare
  • CONMED
  • Hoya
  • CREO Medical
  • Medalkan
  • Medical Devices
  • Metrex Research
  • PurposeBuilt
  • Richard Wolf
  • Summit Imaging
  • NanoSonics
  • Pentax medical
  • Mitra Group
  • CENSIS
  • Sympliant
  • Acuro Organics
  • Becto
  • Brulin
  • Cardinal Health
  • Cetylite
  • Contec
  • Hygiene-Konzepte
  • Lonza
  • Hako Group
  • Pharmax
  • The Clorox
KEY QUESTIONS ANSWERED

1. WHAT IS THE PROJECTED MARKET SIZE & GROWTH RATE OF THE ENDOSCOPE REPROCESSING MARKET?

2. WHAT ARE THE KEY DRIVING FACTORS FOR THE GROWTH OF THE ENDOSCOPE REPROCESSING MARKET?

3. WHICH REGION IS ANTICIPATED TO WITNESS CONSIDERABLE GROWTH IN THE ENDOSCOPE REPROCESSING MARKET?

4. WHICH PRODUCT IS EXPECTED TO HOLD THE LARGEST SHARE IN THE ENDOSCOPE REPROCESSING MARKET?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY END-USER
4.3.3 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
8.1 OVERVIEW
8.1.1 ENDOSCOPE REPROCESSING MARKET
8.1.2 ENDOSCOPE REPROCESSING: MARKET SEGMENTATIONS
8.1.3 COMPETITIVE SCENARIO
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASED FDA EVALUATIONS & APPROVALS OF AUTOMATED ENDOSCOPE REPROCESSORS
9.2 DEMAND FOR ENDOSCOPE REPROCESSING TRACKING SOLUTIONS
9.3 TECHNOLOGICAL ADVANCES IN ENDOSCOPE REPROCESSING METHODS
10 MARKET GROWTH ENABLERS
10.1 INCREASE IN TARGET POPULATION REQUIRING ENDOSCOPIC INTERVENTIONS
10.2 RISK OF ENDOSCOPE-RELATED INFECTIONS
10.3 REGULATORY GUIDELINES THAT PROMOTE ENDOSCOPE REPROCESSING
10.4 HOSPITAL INVESTMENTS IN ENDOSCOPES & RELATED REPROCESSING SYSTEMS
11 MARKET RESTRAINTS
11.1 HIGH COST OF ENDOSCOPE REPROCESSING EQUIPMENT
11.2 SAFETY CONCERNS & LIMITATIONS OF ENDOSCOPE REPROCESSING
11.3 SIDE EFFECTS OF DETERGENTS & DISINFECTANTS
11.4 GROWTH IN POPULARITY OF SINGLE-USE ENDOSCOPES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY PRODUCT
12.2.2 INSIGHTS BY ENDOSCOPE REPROCESSING EQUIPMENT
12.2.3 INSIGHTS BY END-USER
12.2.4 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
14 DISINFECTANTS
14.1 MARKET OVERVIEW
14.2 MARKET SIZE & FORECAST
14.2.1 DISINFECTANTS: MARKET BY GEOGRAPHY
15 REPROCESSING EQUIPMENT
15.1 MARKET OVERVIEW
15.2 MARKET SIZE & FORECAST
15.2.1 REPROCESSING EQUIPMENT: MARKET BY GEOGRAPHY
15.3 AUTOMATED ENDOSCOPE REPROCESSORS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 AUTOMATED ENDOSCOPE REPROCESSORS: MARKET BY GEOGRAPHY
15.4 DISINFECTION & STERILIZATION SYSTEMS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 DISINFECTION & STERILIZATION SYSTEMS: MARKET BY GEOGRAPHY
16 DETERGENTS
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.2.1 DETERGENTS: MARKET BY GEOGRAPHY
17 DRYING, STORAGE & TRANSPORT SYSTEMS
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 DRYING STORAGE, & TRANSPORT SYSTEMS: MARKET BY GEOGRAPHY
18 OTHERS
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 OTHERS: MARKET BY GEOGRAPHY
19 END-USER
19.1 MARKET SNAPSHOT & GROWTH ENGINE
19.2 MARKET OVERVIEW
19.3 HOSPITALS
19.3.1 MARKET OVERVIEW
19.3.2 MARKET SIZE & FORECAST
19.3.3 HOSPITALS: MARKET BY GEOGRAPHY
19.4 SPECIALTY CLINICS & MEDICAL OFFICE SUITES
19.4.1 MARKET OVERVIEW
19.4.2 MARKET SIZE & FORECAST
19.4.3 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: MARKET BY GEOGRAPHY
19.5 STANDALONE REPROCESSING SERVICE FACILITIES
19.5.1 MARKET OVERVIEW
19.5.2 MARKET SIZE & FORECAST
19.5.3 STANDALONE REPROCESSING SERVICE FACILITIES: MARKET BY GEOGRAPHY
19.6 OTHERS
19.6.1 MARKET OVERVIEW
19.6.2 MARKET SIZE & FORECAST
19.6.3 OTHERS: MARKET BY GEOGRAPHY
20 GEOGRAPHY
20.1 MARKET SNAPSHOT & GROWTH ENGINE
20.2 GEOGRAPHIC OVERVIEW
21 NORTH AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 NORTH AMERICA: PRODUCT
21.2.2 NORTH AMERICA: REPROCESSING EQUIPMENT
21.2.4 NORTH AMERICA: END-USER
21.3 KEY COUNTRIES
21.3.1 US: MARKET SIZE & FORECAST
21.3.2 CANADA: MARKET SIZE & FORECAST
22 EUROPE
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 EUROPE: PRODUCT
22.2.2 EUROPE: REPROCESSING EQUIPMENT
22.2.4 EUROPE: END-USER
22.3 KEY COUNTRIES
22.3.1 GERMANY: MARKET SIZE & FORECAST
22.3.2 UK: MARKET SIZE & FORECAST
22.3.3 FRANCE: MARKET SIZE & FORECAST
22.3.4 ITALY: MARKET SIZE & FORECAST
22.3.5 SPAIN: MARKET SIZE & FORECAST
23 APAC
23.1 MARKET OVERVIEW
23.2 MARKET SIZE & FORECAST
23.2.1 APAC: PRODUCT
23.2.2 APAC: REPROCESSING EQUIPMENT
23.2.4 APAC: END-USER
23.3 KEY COUNTRIES
23.3.1 CHINA: MARKET SIZE & FORECAST
23.3.2 JAPAN: MARKET SIZE & FORECAST
23.3.3 INDIA: MARKET SIZE & FORECAST
23.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
23.3.5 AUSTRALIA: MARKET SIZE & FORECAST
24 LATIN AMERICA
24.1 MARKET OVERVIEW
24.2 MARKET SIZE & FORECAST
24.2.1 LATIN AMERICA: PRODUCT
24.2.2 LATIN AMERICA: REPROCESSING EQUIPMENT
24.2.4 LATIN AMERICA: END-USER
24.3 KEY COUNTRIES
24.3.1 BRAZIL: MARKET SIZE & FORECAST
24.3.2 MEXICO: MARKET SIZE & FORECAST
24.3.3 ARGENTINA: MARKET SIZE & FORECAST
25 MIDDLE EAST & AFRICA
25.1 MARKET OVERVIEW
25.2 MARKET SIZE & FORECAST
25.2.1 MIDDLE EAST & AFRICA: PRODUCT
25.2.2 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT
25.2.4 MIDDLE EAST & AFRICA: END-USER
25.3 KEY COUNTRIES
25.3.1 TURKEY: MARKET SIZE & FORECAST
25.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
25.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
25.3.4 UAE: MARKET SIZE & FORECAST
26 COMPETITIVE LANDSCAPE
26.1 COMPETITION OVERVIEW
26.2 MARKET SHARE ANALYSIS
26.2.1 STERIS
26.2.2 ECOLAB
26.2.3 GETINGE
26.2.4 OLYMPUS
26.2.5 FORTIVE
27 KEY COMPANY PROFILES
27.1 STERIS
27.1.1 BUSINESS OVERVIEW
27.1.2 PRODUCT OFFERINGS
27.1.3 KEY STRATEGIES
27.1.4 KEY STRENGTHS
27.1.5 KEY OPPORTUNITIES
27.2 ECOLAB
27.2.1 BUSINESS OVERVIEW
27.2.2 PRODUCT OFFERINGS
27.2.3 KEY STRATEGIES
27.2.4 KEY STRENGTHS
27.2.5 KEY OPPORTUNITIES
27.3 GETINGE AB
27.3.1 BUSINESS OVERVIEW
27.3.2 PRODUCT OFFERINGS
27.3.3 KEY STRATEGIES
27.3.4 KEY STRENGTHS
27.3.5 KEY OPPORTUNITIES
27.4 OLYMPUS
27.4.1 BUSINESS OVERVIEW
27.4.2 PRODUCT OFFERINGS
27.4.3 KEY STRATEGIES
27.4.4 KEY STRENGTHS
27.4.5 KEY OPPORTUNITIES
27.5 FORTIVE
27.5.1 BUSINESS OVERVIEW
27.5.2 PRODUCT OFFERINGS
27.5.3 KEY STRATEGIES
27.5.4 KEY STRENGTHS
27.5.5 KEY OPPORTUNITIES
28 OTHER PROMINENT VENDORS
28.1 3M
28.1.1 BUSINESS OVERVIEW
28.1.2 PRODUCT OFFERINGS
28.2 ACURO ORGANICS LIMITED
28.2.1 BUSINESS OVERVIEW
28.2.2 PRODUCT OFFERINGS
28.3 ATMS
28.3.1 BUSINESS OVERVIEW
28.3.2 PRODUCT OFFERINGS
28.4 BECTO
28.4.1 BUSINESS OVERVIEW
28.4.2 PRODUCT OFFERINGS
28.5 BES HEALTHCARE
28.5.1 BUSINESS OVERVIEW
28.5.2 PRODUCT OFFERINGS
28.6 BRULIN
28.6.1 BUSINESS OVERVIEW
28.6.2 PRODUCT OFFERINGS
28.7 CARDINAL HEALTH
28.7.1 BUSINESS OVERVIEW
28.7.2 PRODUCT OFFERINGS
28.8 CENSIS
28.8.1 BUSINESS OVERVIEW
28.8.2 PRODUCT OFFERINGS
28.9 CETYLITE
28.9.1 BUSINESS OVERVIEW
28.9.2 PRODUCT OFFERINGS
28.10 CONMED
28.10.1 BUSINESS OVERVIEW
28.10.2 PRODUCT OFFERINGS
28.11 CONTEC
28.11.1 BUSINESS OVERVIEW
28.11.2 PRODUCT OFFERINGS
28.12 CREO MEDICAL
28.12.1 BUSINESS OVERVIEW
28.12.2 PRODUCT OFFERINGS
28.13 HAKO GROUP
28.13.1 BUSINESS OVERVIEW
28.13.2 PRODUCT OFFERINGS
28.14 HOYA
28.14.1 BUSINESS OVERVIEW
28.14.2 PRODUCT OFFERINGS
28.15 HYGIENE-KONZEPTE
28.15.1 BUSINESS OVERVIEW
28.15.2 PRODUCT OFFERINGS
28.16 LONZA
28.16.1 BUSINESS OVERVIEW
28.16.2 PRODUCT OFFERINGS
28.17 MEDALKAN
28.17.1 BUSINESS OVERVIEW
28.17.2 PRODUCT OFFERINGS
28.18 MEDICAL DEVICES GROUP SRL
28.18.1 BUSINESS OVERVIEW
28.18.2 PRODUCT OFFERINGS
28.19 METALL ZUG AG
28.19.1 BUSINESS OVERVIEW
28.19.2 PRODUCT OFFERINGS
28.20 METREX RESEARCH
28.20.1 BUSINESS OVERVIEW
28.20.2 PRODUCT OFFERINGS
28.21 MITRA GROUP
28.21.1 BUSINESS OVERVIEW
28.21.2 PRODUCT OFFERINGS
28.22 NANOSONICS
28.22.1 BUSINESS OVERVIEW
28.22.2 PRODUCT OFFERINGS
28.23 PENTAX MEDICAL
28.23.1 BUSINESS OVERVIEW
28.23.2 PRODUCT OFFERINGS
28.24 PHARMAX
28.24.1 BUSINESS OVERVIEW
28.24.2 PRODUCT OFFERINGS
28.25 PURPOSEBUILT BRANDS
28.25.1 BUSINESS OVERVIEW
28.25.2 PRODUCT OFFERINGS
28.26 RICHARD WOLF GMBH
28.26.1 BUSINESS OVERVIEW
28.26.2 PRODUCT OFFERINGS
28.27 SUMMIT IMAGING
28.27.1 BUSINESS OVERVIEW
28.27.2 PRODUCT OFFERINGS
28.28 SYMPLIANT
28.28.1 BUSINESS OVERVIEW
28.28.2 PRODUCT OFFERINGS
28.29 THE CLOROX COMPANY
28.29.1 BUSINESS OVERVIEW
28.29.2 PRODUCT OFFERINGS
28.30 TUTTNAUER
28.30.1 BUSINESS OVERVIEW
28.30.2 PRODUCT OFFERINGS
29 REPORT SUMMARY
29.1 KEY TAKEAWAYS
29.2 STRATEGIC RECOMMENDATIONS
30 QUANTITATIVE SUMMARY
30.1 MARKET BY PRODUCT
30.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
30.1.2 EUROPE: PRODUCT SEGMENTATION
30.1.3 APAC: PRODUCT SEGMENTATION
30.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
30.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
30.2 MARKET BY REPROCESSING EQUIPMENT
30.2.1 NORTH AMERICA: REPROCESSING EQUIPMENT SEGMENTATION
30.2.2 EUROPE: REPROCESSING EQUIPMENT SEGMENTATION
30.2.3 APAC: REPROCESSING EQUIPMENT SEGMENTATION
30.2.4 LATIN AMERICA: REPROCESSING EQUIPMENT SEGMENTATION
30.2.5 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT SEGMENTATION
30.3 MARKET BY END-USER
30.3.1 NORTH AMERICA: END-USER SEGMENTATION
30.3.2 EUROPE: END-USER SEGMENTATION
30.3.3 APAC: END-USER SEGMENTATION
30.3.4 LATIN AMERICA: END-USER SEGMENTATION
30.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
30.4 MARKET BY GEOGRAPHY
30.4.1 DISINFECTANTS: GEOGRAPHY SEGMENTATION
30.4.2 REPROCESSING EQUIPMENT: GEOGRAPHY SEGMENTATION
30.4.3 DETERGENTS: GEOGRAPHY SEGMENTATION
30.4.4 DRYING, STORAGE, & TRANSPORT SYSTEMS: GEOGRAPHY SEGMENTATION
30.4.5 OTHERS: GEOGRAPHY SEGMENTATION
30.4.6 AUTOMATED ENDOSCOPE REPROCESSORS: GEOGRAPHY SEGMENTATION
30.4.7 DISINFECTION & STERILIZATION SYSTEMS: GEOGRAPHY SEGMENTATION
30.4.8 HOSPITALS: GEOGRAPHY SEGMENTATION
30.4.9 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: GEOGRAPHY SEGMENTATION
30.4.10 STANDALONE REPROCESSING SERVICE FACILITIES: GEOGRAPHY SEGMENTATION
30.4.11 OTHERS: GEOGRAPHY SEGMENTATION
31 APPENDIX
31.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings